---
title: "BRIEF-Lazard LAZARD Q3 ADJUSTED EPS USD 0.56 VS. IBES ESTIMATE USD 0.45"
description: "Oct 23 (Reuters) - Lazard Q3 revenue USD 748 million vs. IBES estimate USD 719.5 million.LAZARD Q3 EPS USD 0.65LAZARD Q3 ASSETS UNDER MANAGEMENT USD 264,537 MILLION"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262404234.md"
published_at: "2025-10-23T10:30:47.000Z"
---

# BRIEF-Lazard LAZARD Q3 ADJUSTED EPS USD 0.56 VS. IBES ESTIMATE USD 0.45

> Oct 23 (Reuters) - Lazard Q3 revenue USD 748 million vs. IBES estimate USD 719.5 million.LAZARD Q3 EPS USD 0.65LAZARD Q3 ASSETS UNDER MANAGEMENT USD 264,537 MILLION

Oct 23 (Reuters) - Lazard Q3 revenue USD 748 million vs. IBES estimate USD 719.5 million.

-   LAZARD Q3 EPS USD 0.65
-   LAZARD Q3 ASSETS UNDER MANAGEMENT USD 264,537 MILLION

### Related Stocks

- [LAZ.US - Lazard](https://longbridge.com/en/quote/LAZ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE \| LAZ Stock News | Lazard, Inc. has expanded its Healthcare Services team with the addition of John Koski and Rob Lowe as Managing Director | [Link](https://longbridge.com/en/news/276227679.md) |
| REG - Scottish Oriental - Holding(s) in Company | Scottish Oriental Smaller Companies Trust PLC announced that Lazard Asset Management LLC has crossed the threshold of 5. | [Link](https://longbridge.com/en/news/275764637.md) |
| Lazard Nears Inflection As Bank Of America Initiates Coverage At Buy | Lazard Inc (NYSE:LAZ) is nearing a pivotal point, according to Bank of America analyst Ebrahim Poonawala, who initiated  | [Link](https://longbridge.com/en/news/273725775.md) |
| Similarweb Q4 Earnings Report: What Investors Need to Know | Similarweb (NYSE:SMWB) reported its Q4 earnings on February 17, 2026, beating estimated earnings by 400%, with an EPS of | [Link](https://longbridge.com/en/news/276170250.md) |
| Downgraded Earnings Outlook and Limited Upside Drive Sell Rating on Lazard | Analyst Ryan Kenny from Morgan Stanley has maintained a Sell rating on Lazard, with a price target of $59.00. This decis | [Link](https://longbridge.com/en/news/271782719.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.